Erschienen in:
01.07.2014 | Brief Communication
Hypoglycemia after Roux-en-Y Gastric Bypass: The BOLD Experience
verfasst von:
Hafiz Sarwar, William H. Chapman III, John R. Pender, Andrada Ivanescu, Almond J. Drake III, Walter J. Pories, Moahad S. Dar
Erschienen in:
Obesity Surgery
|
Ausgabe 7/2014
Einloggen, um Zugang zu erhalten
Excerpt
Obesity is a global epidemic associated with higher mortality and increased incidence of type 2 diabetes, hypertension, and obstructive sleep apnea [
1]. Although dietary and lifestyle interventions can achieve modest weight loss, they are difficult to sustain over the long-term [
2]. Patients are increasingly turning to bariatric surgery to achieve greater weight loss and increase remission of type 2 diabetes, hypertension, and obstructive sleep apnea. Roux-en-y gastric bypass (RYGB) is one of the most commonly performed bariatric procedures due to its safety (mortality ~0.5 %), efficacy in weight loss (~60 % excess weight lost), and disease remission (77 % for type 2 diabetes, 62 % for hypertension, 86 % for obstructive sleep apnea) [
3]. …
